Bruno de Bezerril Andrade

Medical researcher with a focus on clinical research and human immunology. He is dedicated to studying diagnostic and prognostic biomarkers associated with the pathogenesis of infectious diseases of great relevance to public health. A graduate of the Federal University of Bahia (UFBA), he completed his Ph.D. in Human Pathology at the Oswaldo Cruz Foundation, followed by a postdoctoral fellowship at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Currently, he works as a senior researcher, chief of the Laboratory of Clinical and Translational Research at the Gonçalo Moniz Institute, Oswaldo Cruz Foundation, in Salvador, Bahia. At this institution, he served as a member of the Deliberative Council between 2002 and 2024. Additionally, he serves as a professor/consultant for medical courses at Zarns Salvador College, UNIFACS, and in the postgraduate program at the Bahiana School of Medicine and Public Health (EBMSP). He holds the position of research coordinator and international relations at Clariens Educação, a subsidiary of the Mubadala Capital group in the United Arab Emirates.He leads a multinational translational medicine group that integrates experimental and clinical data to describe the inflammatory pathways involved in the immunopathogenesis of diseases such as tuberculosis, HIV, viral hepatitis, arboviruses, malaria, leishmaniasis, and bacterial pneumonia. He heads a collaborative network of laboratories in South Africa (University of Cape Town), India (National Institute for Research in Tuberculosis), China (Henan Chest Hospital), and the United States (Vanderbilt University Medical Center and Johns Hopkins University School of Medicine), where he conducts studies to validate results in locations with distinct epidemiological profiles.Since 2019, he has played the role of co-principal investigator in the Regional Prospective Observational Research for Tuberculosis (RePORT) International consortium and is the principal investigator of this consortium in Brazil (RePORT Brazil). He is a full member of the Academy of Sciences of Bahia, the National Academy of Medicine (Young Leadership category), the Interacademy Medical Panel (Germany), and the Royal Society of Medicine (England). Additionally, he is a permanent member of the Collaboration for TB Vaccine Discovery (CTVD, Gates Foundation).In terms of editorial involvement, he was the founding editor and Section Chief Editor of the Frontiers in Tropical Diseases journal, an Associate Editor of the BMC Infectious Diseases journal, and a regular reviewer for prestigious journals such as the New England Journal of Medicine, Lancet, Science Translational Medicine, JAMA, and Nature Medicine. He also serves as a reviewer and consultant for the Wellcome Trust (England), Francis Crick Institute (England), and the World Health Organization, in addition to CNPq and FAPESB. He brings extensive experience in projects with international funding from institutions such as the National Institutes of Health, Wellcome Trust, Gates Foundation, United Nations (UN), and the World Health Organization (WHO).